HIV, Gilead
1h
Montgomery Advertiser on MSNAlabama still fighting HIV: 'In the South is where we have the majority of the problems':Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...
12hon MSN
A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...
Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...
Researchers here described how they were able to safely and ethically enroll adolescents in a landmark trial of a drug that ...
UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...
To reduce care disparities and prevent them from exacerbating among people living with HIV who have long COVID, education and ...
Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...
A patient told MassLive she was horrified to receive a phone call from her surgeon post-operation saying she should be tested for bloodborne pathogens.
Prominent gaps in pediatric and adolescent HIV care translate into priorities that need to be addressed for optimizing care ...
Without urgent intervention, Kenya risks a surge in new HIV infections, which currently stand at 16,752 annually, NSDCC said.
1d
Newspoint on MSNGet one injection in a year and get rid of the tension of HIV! It can be a boon for such peopleScientists have got success with a new injection of HIV. Taking this injection once a year can reduce the risk of HIV ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results